NHS
Science & DTx
For business
Solutions
Clinicians
Investors
About us
Contact us
FacebookTwitterLinkedinYouTube

Dr Andy Richards CBE

The Board

Andy is an entrepreneur and investor with an established track record in founding and scaling up innovative Biotech and Healthtech companies in the UK.

In addition to his Directorship at Ieso, he is also Chairman of Arecor, Congenica, Abcodia, Closed Loop Medicine and Babraham Bioscience Technologies Ltd (BBT) and is a Director of Owlstone Medical and Cancer Research Technology (commercial board of CR-UK). He is an advisor to several investment funds including Cambridge Innovation Capital and the UCL Technology Fund and was, until recently, a director of Cambridge University Hospitals NHS Foundation Trust.

Andy is a Cambridge Graduate with a PhD in Chemistry and an early career spanning positions with ICI (now AstraZeneca) and PA Technology. He was a founder and executive director of Chiroscience plc until its merger with Celltech in 1999 and since that time he has founded, invested in and helped to scale more than 25 innovative ventures including companies such as Vectura, Arakis, Cambridge Biotechnology Ltd and Geneservice. Andy is also a founder member of the Cambridge Angels. He received a CBE for services to life-science investment in 2015.

The Board and Leadership Team

Dr Andy Blackwell

Group Chief Science & Strategy Officer

Clare Hurley

Chief Operating Officer (UK)

Dr Jodi Prohofsky

Chief Operating Officer (US)

Danah Tangen

Chief of Staff

Dr Valentin Tablan

Chief Artificial Intelligence Officer

Kate Woolland

Chief Delivery Officer

James Kellerman

Chief Technology Officer

Dr Charlotte Housden

(Maternity leave)

Stephen Freer

EVP Clinical

Dr Andrew Welchman

EVP Impact

Siobhan Brown

Head of HR

Robert Spavin

EVP Legal & IP

Jordan Elliott

Director of Product & Design